BDF Gestion’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8M Sell
51,301
-5,768
-10% -$313K 0.37% 69
2026
Q1
$3.58M Buy
57,069
+19,023
+50% +$1.52M 0.48% 49
2025
Q4
$3.63M Sell
38,046
-2,536
-6% -$249K 0.44% 49
2025
Q3
$3.96M Buy
40,582
+3,585
+10% +$371K 0.47% 51
2025
Q2
$3.97M Sell
36,997
-4,032
-10% -$408K 0.44% 57
2025
Q1
$4.14M Hold
41,029
0.45% 59
2024
Q4
$3.66M Sell
41,029
-5,329
-11% -$469K 0.38% 67
2024
Q3
$3.86M Hold
46,358
0.41% 65
2024
Q2
$3.57M Buy
+46,358
New +$3.39M 0.34% 72

Other funds holding BSX

BDF Gestion's BSX Position: Q2 2026 in Review

BDF Gestion reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $313K and leaving 51,301 shares worth $2.8M. The position accounts for 0.37% of the portfolio, ranked #69.

BDF Gestion first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.14M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BDF Gestion held 51,301 shares of Boston Scientific worth $2.8M as of Q2 2026.
  • BDF Gestion sold 5,768 Boston Scientific shares in Q2 2026, an estimated $313K.
  • Boston Scientific made up 0.37% of BDF Gestion's portfolio in Q2 2026, its #69 holding.
  • BDF Gestion first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • BDF Gestion's Boston Scientific position peaked at $4.14M in Q1 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.